Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bjarke á Rogvi-Hansen

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Epilepsy & Behavior : E&B|July 10, 2008
Diurnal lamotrigine plasma level fluctuations: clinical significance and indication of shorter half-life with chronic administrationKirsten A Nielsen, Marit Dahl, Erling Tømmerup, et al.
Epilepsia|August 27, 2010
Novel mutations in EPM2A and NHLRC1 widen the spectrum of Lafora diseaseGaetan Lesca, Nadia Boutry-Kryza, Bertrand de Toffol, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Epilepsy & Behavior : E&B|July 10, 2008
Diurnal lamotrigine plasma level fluctuations: clinical significance and indication of shorter half-life with chronic administrationKirsten A Nielsen, Marit Dahl, Erling Tømmerup, et al.
Epilepsia|August 27, 2010
Novel mutations in EPM2A and NHLRC1 widen the spectrum of Lafora diseaseGaetan Lesca, Nadia Boutry-Kryza, Bertrand de Toffol, et al.
Pageof 1